TrialJCO precision oncology2022

Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.

Jillian A Moran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.